Pulmonary TB

13 registered clinical trials studyying Pulmonary TB — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease NCT07118696	Hamilton Health Sciences Corporation	Phase 3
Active Not Recruiting	Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pu NCT06058299	Global Alliance for TB Drug Development	Phase 2
Completed	Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants Wit NCT05221502	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 2
Recruiting	Risk Factors and Biomarkers for Post-tuberculosis Lung Damage NCT05426720	Peking University Third Hospital	—
Completed	Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Managem NCT04645836	Xi'an Jiaotong University	N/A
Unknown	Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text M NCT04264221	Farman Ullah Khan	N/A
Completed	Xpert MTB/RIF Ultra Trial NCT07135622	Nestani Tukvadze	N/A
Completed	A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis NCT03678688	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 1 / Phase 2
Completed	Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults NCT03722472	Access to Advanced Health Institute (AAHI)	Phase 1
Unknown	Performance Evaluation of TB Breath- and Cough-testing Platforms NCT03025516	Find	—
Completed	Comparison Between Two Strategies for the Diagnosis of TB NCT02961569	Hopital Lariboisière	N/A
Completed	Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis NCT00933790	Tuberculosis Research Centre, India	Phase 3
Completed	Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb NCT00212550	NYU Langone Health	—